| 1 |
29954720 | Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel. | 2019 Apr |
1 |
| 2 |
30422043 | Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment. | 2019 |
1 |
| 3 |
30228021 | Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry. | 2018 Dec 15 |
2 |
| 4 |
25896573 | Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis. | 2015 Apr |
2 |
| 5 |
24952863 | Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial. | 2014 Jul |
1 |
| 6 |
25634391 | Safety of Prasugrel in Indian patients - multicentric registry of 1000 cases. | 2014 Nov-Dec |
1 |
| 7 |
22965108 | Comparison of prasugrel and clopidogrel in the setting of ACS without revascularization. | 2012 Nov |
1 |
| 8 |
20107305 | Reducing cardiac ischemic events in patients with ACS: prasugrel versus clopidogrel. Commentary. | 2010 Jan |
2 |
| 9 |
20598967 | Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. | 2010 Jul |
1 |
| 10 |
19520305 | Diabetes and acute coronary syndromes. | 2009 Jun |
1 |
| 11 |
18611364 | Should Prasugrel or Clopidogrel Be Used in Patients with ACS? | 2008 Jul |
1 |